| 0 (0%) | 05-12 20:11 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 29.2 | 1-year : | 29.67 |
| Resists | First : | 25 | Second : | 25.4 |
| Pivot price | 24.83  |
|||
| Supports | First : | 24.35 | Second : | 20.26 |
| MAs | MA(5) : | 24.8 | MA(20) : | 24.8 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.1  |
Signal : | -0.1 |
| %K %D | K(14,3) : | 49.1 |
D(3) : | 49.6 |
| RSI | RSI(14): 47.1 |
|||
| 52-week | High : | 25.4 | Low : | 24.35 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ JHCP ] has closed above bottom band by 41.9%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 24.82 - 24.94 | 24.94 - 25.05 |
| Low: | 24.49 - 24.63 | 24.63 - 24.77 |
| Close: | 24.58 - 24.8 | 24.8 - 25 |
Mon, 17 Feb 2025
FY24 Annual Report - Johns Hopkins Medicine
Mon, 17 Feb 2025
FY24 Annual Report: Nursing Satisfaction Up Amid Growth and Innovation - Johns Hopkins Medicine
Wed, 18 Dec 2024
John Hancock Unveils 2 New Active Bond ETFs - ETF Trends
Tue, 09 Jan 2024
FY23 Annual Report: Frontline Primary Care Panel Helps Fine Tune Research Studies - Johns Hopkins Medicine
Tue, 09 Jan 2024
FY23 Annual Report: Growth - Johns Hopkins Medicine
Thu, 24 Aug 2023
FY20 Annual Report: Credentialing - Johns Hopkins Medicine
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|